PP121 and Carcinoma--Hepatocellular

PP121 has been researched along with Carcinoma--Hepatocellular* in 1 studies

Other Studies

1 other study(ies) available for PP121 and Carcinoma--Hepatocellular

Article	Year
Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma. European journal of medicinal chemistry, 2021, Dec-05, Volume: 225 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Hep G2 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Liver Neoplasms; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Protein Kinases; Pyrimidines; Rats; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Tumor Cells, Cultured	2021

Article

Year

Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.

European journal of medicinal chemistry, 2021, Dec-05, Volume: 225

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Hep G2 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Liver Neoplasms; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Protein Kinases; Pyrimidines; Rats; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2021